Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
[HTML][HTML] Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - BMJ, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar… - BMJ, 2020 - sonar.ch
Methods After duplicate data abstraction, a Bayesian network meta-analysis was conducted.
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
[HTML][HTML] Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - The BMJ, 2020 - ncbi.nlm.nih.gov
Methods After duplicate data abstraction, a bayesian network meta-analysis was conducted.
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar… - 2020 - open.library.ubc.ca
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources US Centers for …
Design Living systematic review and network meta-analysis. Data sources US Centers for …
Drug treatments for covid-19: Living systematic review and network meta-Analysis
RAC Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar… - The …, 2020 - research.monash.edu
AbstractObjective To compare the effects of treatments for coronavirus disease 2019 (covid-
19). Design Living systematic review and network meta-Analysis. Data sources US Centers …
19). Design Living systematic review and network meta-Analysis. Data sources US Centers …
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, G Long… - BMJ: British Medical …, 2020 - search.proquest.com
Methods After duplicate data abstraction, a bayesian network meta-analysis was conducted.
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Drug treatments for covid-19: living systematic review and network meta-analysis
RA Siemieniuk, JJ Bartoszko… - BMJ (Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, D Zeraatkar, E Kum… - BMJ, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
compare the effects of treatments for coronavirus disease 2019 (covid-19).</jats: p></jats …
compare the effects of treatments for coronavirus disease 2019 (covid-19).</jats: p></jats …
Drug treatments for covid-19: living systematic review and network meta-analysis
RAC Siemieniuk, JJ Bartoszko, L Ge, D Zeraatkar… - BMJ, 2020 - folia.unifr.ch
Methods After duplicate data abstraction, a Bayesian network meta-analysis was conducted.
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …
Risk of bias of the included studies was assessed using a modification of the Cochrane risk …